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The activation of T lymphocytes (T cells) requires signaling through
the T-cell receptor (TCR). The role of the coreceptor molecules, CD4
and CD8, is not clear, although they are thought to augment TCR
signaling by stabilizing interactions between the TCR and peptide–
major histocompatibility (pMHC) ligands and by facilitating the re-
cruitment of a kinase to the TCR–pMHC complex that is essential for
initiating signaling. Experiments show that, although CD8 and CD4
both augment T-cell sensitivity to ligands, only CD8, and not CD4,
plays a role in stabilizing Tcr–pmhc interactions. We developed
amodel of TCR and coreceptor binding and activation and ﬁnd that
these results can be explained by relatively small differences in the
MHC binding properties of CD4 and CD8 that furthermore suggest
that the role of the coreceptor in the targeted delivery of Lck to the
relevant TCR-CD3 complex is their most important function.
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Membrane proteins CD4 and CD8 are expressed on T helpercells and cytotoxic T lymphocytes, respectively, that are
known to augment the sensitivity and response of T cells to cognate
peptide–major histocompatibility (pMHC) ligands (1–3). It is
generally thought that the ability of these coreceptors to enhance
T-cell responses is due to twomain effects: (i) Binding of CD4 and
CD8 to MHC class II and class I molecules helps stabilize weak
T-cell receptor (TCR)-pMHC interactions; and (ii) the Src kinase,
Lck, which is bound to the cytoplasmic tail of coreceptors, is efﬁ-
ciently recruited to the TCR complex upon coreceptor binding to
theMHC, thereby enhancing the initiation of TCR signaling (3, 4).
Surface plasmon resonance (SPR) analyses show that the half-
lives characterizing coreceptor–MHC interactions are <35 ms (off
rate>20 s−1, the resolution of SPR instruments) for both CD4 and
CD8 (5–7). It is difﬁcult to understand how the two effects noted
above can be potentiated by such ﬂeeting interactions. For ex-
ample, consider the effect of coreceptor–MHC interactions in
stabilizing the TCR-pMHC complex. A typical agonist pMHC li-
gand is bound to a TCR for ≈10,000 ms (corresponding to an off
rate of 0.1 s−1) (8). Thus, during the lifetime of the TCR–pMHC
bond a coreceptor would disengage from the MHC ≈1,000 times,
making it implausible that stabilization of TCR–pMHC inter-
actions would be achieved. Recent data measuring TCR binding
within a synapse (9) show that it is less stable, perhaps 1,000 ms for
an average TCR–ligand interaction due to actin polymerization
activity, but this is still far in excess of what has been reported for
CD4 and CD8 interactions.
However, CD8 has been found to stabilize pMHC binding to
CD8+ T-cell surfaces (10, 11) and augment sensitivity (2, 12). In
contrast, past studies (13, 14) and recent in situ measurements at
intercellular junctions show that CD4 does not stabilize the inte-
ractions of TCRwith class II pMHCmolecules (9). However, CD4
does enhance the sensitivity of T helper cells (1, 9, 15, 16). As the
binding afﬁnity of CD4 for the MHC ectodomain has been re-
ported to be just two to four times weaker than that characterizing
CD8-MHC interactions (5), and the half-lives of both coreceptor
MHC interactions are 1,000-fold shorter than the TCR-agonist
pMHC bond, these results are difﬁcult to reconcile.
Our results provide a conceptual framework that uniﬁes these,
and other, observations regarding the role of CD4 and CD8 on
T-cell signaling and reveal how they function.
Results
To shed light on the puzzles noted above and to understand the
potentially different ways in which CD4 and CD8 may augment
TCR signaling, we carried out computer simulations (Methods and
below) of the well-established earliest events in TCR signaling.
Kinetic Reasons Underlie Why CD8, but Not CD4, Can Stabilize TCR–
pMHC Interactions. First, we studied whether coreceptors can stabi-
lize TCR–pMHC interactions. For these simulations we assumed
a T-cell–antigen-presenting cell (APC) interface of 1 μm2-area
containing 300 T-cell receptors, 100 coreceptors, and 100 pMHC
complexes (these concentrations are typical for in vitro experiments)
(17). The biochemical reactions that could occur upon the appro-
priate proteins encountering each other were (scheme 1 in Fig. 1)
TCR–pMHC binding and unbinding, coreceptor binding to MHC,
and coreceptor binding to TCR via Lck (Fig. 1). TCR, coreceptors,
and pMHC were allowed to diffuse on the T-cell and APC surface.
To determine the apparent dissociation rate of pMHCmolecules off
the T-cell surface we initialized the simulation with 100 pMHC
proteins bound to TCRs. We then simulated the biochemical reac-
tions noted above, using the Stochastic Simulation Compiler (18)
that allows the efﬁcient implementation of the Gillespie algorithm
(Methods and ref. 19) to study cell signaling processes, including
proteinmotion and stochastic effects (details in SIMethods). Several
replicate simulations for each scenario were carried out, and average
values of the dissociation rate of pMHCproteins in the presence and
absence of coreceptors were obtained.
If a pMHC molecule dissociated from the T-cell surface during
the simulation, we removed it, thereby preventing rebinding. This
removal mimics experiments where antibodies are used to achieve
the same end. The parameters used to simulate situations with and
without coreceptors were identical (Table 1), and we studied the
effects of varying the dissociation rate of the coreceptor–MHCbond
(koff), keeping the on rate the same. These calculations aimed to
explore whether the higher afﬁnity of CD8 forMHC class I proteins,
versus CD4-MHC class II interactions, could explain why CD8, but
not CD4, is observed to stabilize TCR–pMHC interactions (9–11,
13, 14, 20).
On the basis of the arguments noted above, we expected differ-
ences in the half-life of coreceptor–MHC interactions to have
Author contributions: M.N.A. and A.K.C. designed research; M.N.A. performed research;
M.L. and S.D. contributed new reagents/analytic tools; M.N.A., M.M.D., and A.K.C. ana-
lyzed data; and M.N.A., M.M.D., and A.K.C. wrote the paper.
The authors declare no conﬂict of interest.
Freely available online through the PNAS open access option.
1To whom correspondence may be addressed. E-mail: mdavis@cmgm.stanford.edu or
arupc@mit.edu.
This article contains supporting information online at www.pnas.org/lookup/suppl/doi:10.
1073/pnas.1010568107/-/DCSupplemental.
16916–16921 | PNAS | September 28, 2010 | vol. 107 | no. 39 www.pnas.org/cgi/doi/10.1073/pnas.1010568107
a minimal effect on the dissociation rate of pMHC molecules from
the T-cell surface. However, our results (Fig. 2A) indicate that this is
not necessarily true. For coreceptor–MHC interactions with a koff
value on the order of 20 s−1, the effective half-life of pMHC mol-
ecules bound to TCRs on the T-cell surface is enhanced by about
a factor of 1.5. However, a fourfold lower coreceptor–MHC afﬁnity
(koff∼ 80 s−1) results in an effective dissociation rate from the T-cell
surface that is indistinguishable from simulation results without the
coreceptor. These results recapitulate the experimental observation
that CD4, which bindsMHC class II proteins with a two- to fourfold
lower afﬁnity compared with CD8 binding to MHC class I (5), does
not stabilize the TCR–pMHC bond, but CD8 does (9–11, 13, 14).
Thus the strikingly different experimental results for CD4 and CD8
(9–11, 13, 14) can be explained on simple kinetic grounds. We also
carried out simulations with values of TCR–pMHC dissociation
rates that are 10 times faster than that used to obtain the results in
Fig. 1 as recent experiments suggest such faster kinetics at the cell–
cell interphase (9). The qualitative results are identical for this sit-
uation Fig. S1.
However, what was wrong with the argument made earlier, which
suggested that the ﬂeeting interactions between MHC proteins and
CD4 or CD8 could not stabilize TCR–pMHC bonds? That argu-
ment did not account for the fact that a coreceptor-associated Lck
also interacts with the TCR through its complex with the CD3
molecules. Thus, a coreceptor’s interactions with a TCR–pMHC
complex are functionally bivalent, with one armbinding to theMHC
and the other to the TCR (cartoon on Right in Fig. 1). If the cor-
eceptor dissociates from the MHC, it is still bound via Lck to the
TCR–pMHC complex, thus allowing rapid rebinding to the MHC.
A similar effect is in play if Lck dissociates from the TCR. Our re-
sults show that such cooperative interactions can cause coreceptor-
mediated stabilization of the TCR–pMHC bond only if coreceptor–
MHC interactions have a dissociation rate not much larger than
20 s−1 Fig. S2.
Main Function of Both CD4 and CD8 Is to Enhance Lck Recruitment,
Not Stabilize TCR–pMHC Interactions. Although CD4 does not sta-
bilize TCR–pMHC interactions (9, 13, 14), like CD8, it does en-
hance T-cell responses (1, 9). This result raises the question of
Fig. 1. Pictorial representation of the computer simulations that were carried out. Three kinds of proteins (MHC, coreceptor, and TCR) were allowed to
diffuse on the surface that represents 1 μm2 of the T-cell–APC interface. Proteins were allowed to interact in accord with the indicated biochemical reactions.
In the ﬁrst set of simulations, reactions from scheme 1 were implemented; in the second set of simulations, reactions from scheme 2 were implemented.
Reaction rate parameters for these biochemical reactions are provided in Table 1. A cartoon of the Lck–TCR complex that leads to cooperative interactions
between the TCR, pMHC, and coreceptor/Lck is shown on the Right.
Table 1. Rate parameters (in units per second) used in simulations
Rate parameter, s−1 Reaction described
150* kon,TCR-MHC: TCR-MHC on rate (exp ∼ 104 M−1·s−1)
0.02* koff,TCR-AgMHC: TCR-MHC off rate for agonist peptide (exp ∼ 0.02 s−1)
1000* kon,CD4(8)-MHC: MHC–coreceptor (CD4/CD8) on rate (exp ∼ 105 M−1·s−1)
20* koff,CD4(8)-MHC: MHC–coreceptor (CD4/CD8) off rate (exp ∼ 20 s−1)
50* kdiff: rate of diffusion of membrane surface proteins (exp ∼ 0.01 μm2·s−1)
20* koff,TCR-EnMHC: TCR-MHC off rate for endogenous peptide (exp ∼ 20 s−1)
0.05 kp: rate of phosphorylation of TCR/CD3 by Lck
0.2 kdp: rate of dephosphorylation of TCR/CD3
1 kon,Lck–TCR: rate of Lck engagement with TCR/CD3
1 koff,Lck–TCR: rate of Lck disengagement with TCR/CD3
Experimentally derived parameters are marked with an asterisk. (see ref. 5 for references). Unit conversion
rules are detailed in SI Methods. There are no experimental data available for black entries. See SI Methods and
Figs. S3–S6 showing that our qualitative conclusions do not change upon varying these parameters, except if Lck
does not associate with TCR.
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whether CD4 can enhance Lck recruitment to the TCR complex
and, more generally, whether CD4 and CD8 enhance T-cell sensi-
tivity to antigen in different ways.
To examine these issues, we carried out computer simulations
of the type used to obtain the results in Fig. 2A except that the set
of possible biochemical reactions was augmented to include one of
the earliest events in TCR signaling, phosphorylation of the TCR
immunoreceptor tyrosine-based phosphorylation motifs (ITAMs)
by Lck (scheme 2 in ﬁgure 1 of ref. 35). Multiple phosphorylation
states of the ITAMs on ζ-chains of the TCR were represented by
two phosphorylation states—partially and fully phosphorylated
TCRs (see, for example, ref. 21). To assess the role of the cor-
eceptor in TCR triggering, we studied two situations: (i) Lck is
present as a free membrane-associated molecule and there are no
coreceptors, and (ii) Lck is associated with the coreceptor. We
carried out computer simulations for these two situations, with all
parameters being identical (Table 1), and compared the levels of
TCR phosphorylation (readout of signal strength). Varying the off
rate of coreceptor–MHC interactions did not affect the qualitative
results of these simulations (Fig. S7).
Fig. 2B shows simulation results of signal strength as a function
of the off rate characterizing TCR–pMHC interactions. The sim-
ulations correctly recapitulate experimental observations in that
TCR phosphorylation discriminates between stimulatory and
nonstimulatory ligands. The border between stimulating and
nonstimulating peptides (∼0.1–1 s−1 in the simulations carried out
with coreceptors present, black line in Fig. 2B) is dependent on the
on rate of the TCR–pMHC interaction. The simulations corre-
spond to this rate being 104M−1·s−1, as is experimentally measured
for typically good agonists. But for higher values of the on rate,
pMHC ligands that bind TCRwith off rates>1 s−1 are stimulatory.
Importantly, coreceptors clearly enhance TCR phosphoryla-
tion. As shown in Fig. 2B, if a threshold amount of TCR phos-
phorylation is required for downstream digital signaling modules
(22–24) to be activated (resulting in T-cell responses), peptides
that bind to TCR with off rates in the range of 0.04–0.2 s−1 are
stimulatory only when the coreceptor is present, but barely stim-
ulate TCR phosphorylation without the coreceptor. pMHC
ligands that bind TCR with longer half-lives are stimulatory even
without the coreceptor. This result is consistent with reports of
coreceptor-dependent and independent ligands in both CD4 and
CD8 systems (2, 12, 25). Dose–response curves obtained from the
simulations further support this point (Fig. S8).
We used the computational models to parse the relative con-
tributions of TCR–pMHC stabilization and Lck recruitment to
coreceptor-mediated signal enhancement in a way that is difﬁcult
to accomplish experimentally. We carried out computer simu-
lations where the only effect of coreceptors was to enhance Lck
recruitment. This procedure was achieved by simulating systems
where ITAMphosphorylation was allowed only if TCRand pMHC
were directly bonded and not if they were a part of the TCR–
pMHC–coreceptor complex. These simulations showed results
(Fig. 2C) similar to those in Fig. 2B. We also carried out computer
simulations where the only effect of the coreceptor was to enhance
the stability of the TCR–pMHC bond by a factor of 1.5 (per results
in Fig. 2A for koff = 20 s−1, corresponding to CD8–MHC inter-
actions). This effect was realized by simulating situations without
the coreceptor (no enhancement of Lck recruitment), but with
TCR–pMHC half-lives enhanced to mimic coreceptor-mediated
stabilization. The results (blue line, Fig. 2C) show that stabilizing
the TCR–pMHC bond makes only a minor contribution to cor-
Fig. 2. (A) Effective half-life of MHC on the T-cell surface as a function of
koff
MHC-coreceptor (which is proportional to afﬁnity of the MHC–coreceptor
interaction) as obtained in the ﬁrst set of simulations (scheme 1 in Fig. 1). At
koff ∼ 20 s−1 the half-life is enhanced by ∼1.5 times in the presence of cor-
eceptor, whereas at koff ∼ 80 s−1 half-lives with and without coreceptor are
statistically indistinguishable. (B) Levels of TCR phosphorylation as a function
of koff of the TCR–pMHC interaction. The results are obtained from simu-
lations of 1 μm2 of the T-cell–APC contact area with the following protein
concentrations: 300 TCRs/μm2, 100 coreceptors/μm2 (black curve), or no cor-
eceptor present (red curve). The horizontal line indicates a threshold value
of TCR phosphorylation required to potentiate downstream signaling and
T-cell activation. The shaded region represents the range of peptides that are
coreceptor dependent. (C) Signal enhancement measured by TCR phosphory-
lation. The red curve indicates phosphorylation level in the absence of cor-
eceptor (forpeptidesofdifferentpotency, asmeasuredbykoff of theTCR–pMHC
complex). Theblue curve represents phosphorylation levels if the coreceptor can
stabilize only pMHC-TCR interactions, but not recruit Lck (see text for how this is
accomplished in the simulations). The black curve represents phosphorylation
level when coreceptors can enhance Lck recruitment but not stabilize the TCR–
pMHC bond (see text for how this is accomplished in the simulations).
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eceptor-mediated enhancement of TCR signaling. Thus, even for
CD8, the main effect of the coreceptor is to enhance Lck re-
cruitment to the TCR complex, and for CD4 it is the only effect.
The importance of CD8-mediated Lck recruitment for T-cell ac-
tivation is also indicated by data showing that CD8− and CD8+ T
cells are indistinguishable for T-cell activation by allogeneic MHC
alleles (20).
How Short-Lived Coreceptor–MHC Interactions Enhance Lck Recruitment.
An important question emerging from our results is: How can
ﬂeeting CD4-MHC interactions, which do not stabilize the TCR–
pMHC bond, enhance Lck recruitment? To answer this question,
we analyzed the simulation results using the following simple
arguments and calculations.
When two membrane proteins that are capable of binding ap-
proach within the range of a productive interaction, there are two
possible outcomes: The proteins associate and form a complex, or
they diffuse away from each other and likely never interact. These
outcomes are the consequences of two competing driving forces,
attractive interactions pulling them together and random diffusive
forces pushing proteins apart from each other. As both processes
are stochastic, each possible outcome has a certain probability of
occurrence. We calculated the probability for Lck association with
the TCR complex for the case when Lck is coreceptor associated
and when it is not. Differences in these probabilities and their
mechanistic origins shed light on how coreceptors enhance
Lck recruitment.
When Lck is not coreceptor associated, nearby TCR and Lck
molecules can either bind or diffuse away. The on rate of Lck–TCR
association can be estimated in the following way. It has to be large
enough for the time required for TCR-Lck association to be
shorter than the lifetime of strong agonist pMHC-TCR complexes;
otherwise these ligands would not trigger TCR in a coreceptor-
independent way (Fig. 2 and refs. 2 and 12).Also, the time required
for TCR-Lck association must be longer than the lifetime of
endogenous pMHC-TCR bonds to prevent frequent spurious
triggering of TCRs bound to endogenous ligands. These consid-
erations imply that koff;Ag < kon;Lck < koff;En. As Lck association to
the TCR is a surface reaction and can occur only if Lck and TCR
are close to each other (i.e., within the range of interactions), the
units of kon,Lck are the same as that for a ﬁrst-order reaction rate
constant (see detailed description of unit conversion in
SI Methods). Measured TCR–pMHC off rates thus suggest
kon;Lck∼1 s− 1·molec− 1ðarea of interactionÞ. Effects of variations
inkon,Lck are detailed inSIMethods (Fig. S3). The diffusion constant
of membrane-associated proteins is typically 0.01 μm2/s (26). As-
suming the range of interactions to be of the order 100 Å (0.01 μm)
(27), we can compute the rate with which membrane proteins will
leave the range of interactions due to diffusion to be
kmotion≈100 s− 1. To ﬁnd the probability of escape versus binding,
we compare the rates of motion and binding to obtain
PðescapeÞ ¼ kmotion;Lck þ kmotion;TCR
kmotion;Lck þ kmotion;TCR þ kon;Lck ¼
200
201
¼ 0:995
[1]
PðbindingÞ ¼ kon;Lck
2kmotion þ kon;Lck ¼
1
201
¼ 0:005: [2]
These estimates indicate that the likelihood that free Lck will
form a bond with the TCR/CD3 is small and, as shown below, is
much smaller than the corresponding likelihood for Lck that is
associated with the coreceptor.
Now consider the situation when Lck is associated with the
coreceptor. Once the coreceptor is in the vicinity of a TCR–pMHC
complex, it can either diffuse away or bind to the MHC. Experi-
mental measurements (5) estimate the on rate for coreceptor–
MHC interactions to be very large: kon,MHC-CD4(8) > 10
5 M−1·s−1.
This result leads to the following estimate for the two-dimensional
value of this rate parameter (SI Methods): kon,MHC-CD4(8)(2D) =
1,670[(area of interaction)/(molec × s)]. Note that this value is
16 times larger than the rate parameter corresponding to diffusive
motion of proteins away from each other (kmotion ∼ 100 s−1). This
result suggests that the large on rate for coreceptor–MHC inter-
actions will combat diffusive forces effectively, enabling coreceptor
binding to the MHC with a high probability. Also, once this bond
between two proteins anchored to apposed membranes is estab-
lished, diffusion of the coreceptor and the MHC will be severely
slowed down compared with a protein on a single membrane.
These effects allow the coreceptor to effectively localize Lck to the
TCR–pMHC complex and promote its binding.
To estimate the likelihood of successful Lck–TCR association
given that the TCR-MHC–coreceptor complex has been formed,
wemust consider the following possible events: breaking the TCR-
MHC bond (koff ∼ 1 s−1), breaking MHC–coreceptor bond (koff ∼
20 s−1), and forming the TCR-Lck bond (kon ∼ 1 s−1). Following
the argument made earlier to compute the probability of binding
versus diffusion for free Lck, the probability of Lck binding to the
TCR complex is found to be
PðbindingÞ ¼ kon;Lck
koff;MHC-CD4ð8Þ þ koff;TCR-MHC þ kon;Lck
≈
1
20
¼ 0:05:
[3]
Eqs. 2 and 3 show that Lck recruitment to the TCR/CD3 com-
plex is 10 times more likely if it is associated with the coreceptor
compared with when it is present as free Lck.
Discussion
We conclude that coreceptors CD4 and CD8 augment T-cell sig-
naling primarily by enabling efﬁcient recruitment of Lck to the
TCR/CD3 complex. The large on rate of coreceptor–MHC inter-
actions enables efﬁcient recruitment of Lck by combating the
effects of diffusive forces that tend to separate proteins within the
range of interactions. Although, for reasons we have discussed,
CD4 and CD8 have differential ability to stabilize TCR–pMHC
interactions, the impact of this difference in triggering TCR sig-
naling appears to be minimal.
In addition to those noted in the preceding section, several ex-
perimental results support the mechanism proposed here. First, it
follows from themodel that CD8 T cells should still be activated to
a large extent even when CD8/MHC binding has been severely
reduced (but not completely abrogated) because MHC stabiliza-
tion does not play amajor role in signal enhancement by CD8 (Fig.
2C). This result, in fact, has been observed in experiments by Sewell
and coworkers (28), where a panel of MHC class I with mutated
CD8 binding sites (11, 28, 29) was studied. They found that MHC
mutants with a 10-fold weaker than WT afﬁnity for CD8 were still
able to activate T cells to the same extent (28). This result is con-
sistent with our ﬁnding that the strength of CD8-MHC interactions
that stabilize TCR–pMHC interactions contributes little to en-
hancing signaling. Sewell and coworkers also reported thatmutants
unable to bind CD8 were distinctly inferior in activating T cells.
This result is consistent with our ﬁnding that the coreceptor pri-
marily enhances Lck recruitment, which requires coreceptor
binding to MHC with fast kinetics to counteract fast diffusion, but
does not require stable coreceptor–MHC interactions.
Our results suggest that even a large change in the CD8-MHC
binding parameters affects the stability of MHC molecules on the
T-cell surface only mildly. For example, Fig. 2A shows that
changing koff (CD8-MHC) from 60 s
−1 to 40 s−1, which corre-
sponds to a 50% increase in the lifetime of the MHC-CD8 in-
teraction, increases the effective stability of pMHC-TCR
interactions by ∼6% (from 41 to 44 s). This has been observed in
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a panel of mutants that was described above (11, 29). In particular,
a MHC mutant (Q115E) (11, 29) that binds CD8 with ∼50%
greater afﬁnity compared with WT was found to improve MHC
surface stabilization only by ∼4%.
In contrast to these small effects of coreceptor–MHCinteractions
on TCR–pMHC stabilization, our results show that similar mod-
iﬁcations of coreceptor–MHC interactions havemuch larger effects
on T-cell signaling. FromEq. 3 it follows thatmodifying CD8-MHC
interactions has an essentially proportional effect on the re-
cruitment of Lck and, thus, on the earliest signaling events. Indeed,
following earlier studies that established the role of CD8 in ζ-chain
phosphorylation (30), it was found (29) that in spite of the small
difference in MHC stabilization, ζ-chain phosphorylation was in-
creased considerably when stimulating T cells with the Q115E mu-
tant (which has a minute effect on TCR–pMHC interactions). Note
that in ref. 27 only the numberof activatedT cellswasmeasured, but
not actual phosphorylation levels, which turned out to be very sen-
sitive to coreceptor–MHCinteractions in laterexperiments fromthe
same laboratory(28) (although still being above the activation
threshold). These observations suggested that CD8 contributes to
T-cell activation via an unknown mechanism unrelated to surface
stabilization of pMHC (29). Our results reveal this mechanism.
Notably, in the situation when strength of coreceptor–MHC
interaction is increased to very large values, peptide speciﬁcity
becomes unimportant and noncognate peptides can activate
T cells (Fig. S9). This result is consistent with recent experimental
observations (31), where superenhanced CD8-MHC interaction
abrogated requirement for cognate peptide recognition.
The results we report extend past work by Li et al. on the im-
portance of the coreceptor for Lck recruitment and the relevance
of this effect for triggering nearby TCRs that bind to noncognate
peptides (1). Li et al. did not examine whether CD4 contributes to
TCR–pMHC stabilization and the relative importance of this ef-
fect vis-a-vis Lck recruitment. Nor did they consider differences
between CD4 and CD8. The model studied in the present article is
a ﬁne-grained description of one of the steps in the bigger model
simulated in Li et al., using a spatially homogeneous simulation
method. The results emerging from our study add an un-
derstanding of CD4 and CD8 function that was not available be-
fore, especially with regard to differences and similarities between
their roles in TCR triggering. In situ experiments similar to those
recently reported for CD4+ T cells (9) should enable testing of the
predictions made by our study. For example, in contrast to the
CD4 system, blocking CD8 binding should lead to a small increase
in the measured value of the TCR–pMHC dissociation rate.
However, the extent of inhibition of signaling should be compa-
rable to the CD4 system.
Wehope that our study has helped resolve debates and apparent
contradictions between CD4- and CD8-mediated mechanisms of
signal enhancement and will motivate experimentation to further
clarify coreceptor function.
Methods
We focus on chemical reactions taking place on the two-dimensional surface
representing the T-cell–APC interface. A detailed description of the simula-
tion algorithm we use can be found elsewhere (18). The simulations were
carried out with the help of the SSC software (18), which performs spatially
resolved stochastic chemical master-equation simulations (19, 32) and allows
efﬁcient treatment of the combinatorial expansion problem with increasing
size of the biochemical networks (33). SSC simulation codes can be found in
Appendix S1. Note that explicit description of diffusion and spatially in-
homogeneous molecular distributions alleviates the need for additional
parameters that are used in spatially homogeneous simulations to describe
enhancement of binding due to multivalent interactions (33, 34).
According to experimental data, the interfacebetweena T cell andanAPC is
of the order of 1 μm2 (17). In our simulations, it is represented by a square of
dimensions 1 × 1 μm. The simulated surface is divided into square chambers of
the length L = 100 Å (0.01 μm), which implies that we simulate 100 × 100
chambers. The dimensions of the individual chamber are chosen to correspond
to the range of attractive interactions between membrane-bound proteins
(27).We ignore internal degrees of freedom in proteins, andproteins can react
with each other provided that both are in the same chamber (i.e., they are
within the range of interactions). Reactions between the species in different
cells are not permitted. Diffusion of proteins is considered a ﬁrst-order
chemical reaction and is represented by a protein hopping from one chamber
to the neighboring chamber with corresponding rate constant.
The simulation consists of a very large number of repetitions of two basic
operations: (i) choosing the next process that occurs (either a possible reaction
or diffusion) and (ii) choosing the time when the next process happens.
After updating concentrations and positions, these steps are repeated.
We illustrate the procedure behind the ﬁrst step by considering the
molecule A that can either diffuse to the neighboring chamber with rate
constant kmotion or transform into molecule B (as in A→B) with rate constant
kA→B. The probability that diffusion will occur is
PðdiffusionÞ ¼ kmotion
kmotion þ kA→B [4]
PðreactionÞ ¼ kA→B
kmotion þ kA→B ¼ 1−PðdiffusionÞ: [5]
We generate a random number between 0 and 1, and if it is smaller than P
(diffusion), then we make a diffusion move; otherwise we substitute one
molecule of A with B.
The time when a given process determined by the above procedure occurs
is deﬁned by picking a random number from an exponential distribution e−λ,
with the parameter λ ¼ kmotion þ kA→B. This approach implies that, after gen-
erating another random number from 0 to 1, we use the formula
t ¼ 1
kmotion þ kA→Bln

1
rand

: [6]
In SI Methodswe describe in detail how the parameter values are determined.
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SI Methods
Rate Constant Unit Conversion. The processes are characterized by
the rate constants, but it is propensity of the reaction rather than its
rate constant that enters into the expression for relative proba-
bilities. Propensity is deﬁned as reaction ﬂux in a given volume, i.e.,
number of reactions taking place every second. Thus, for
First order reaction A→B
aA→B ¼ kA→B × ð# of molecules A per chamberÞ; [S1a]
which for the case of the single molecule coincides with rate
constant aA→B ¼ kA→B. This result explains why Eqs. 1 and 2
have rate constants in them.
Second order reactions A+B→C
aAþB→C ¼ kAþB→C × ð# of molecules A per chamberÞ
× ð# of molecules B per chamberÞ: [S1b]
Diffusion of molecules A out of the particular chamber
adiff A ¼ kdiff A × ð# of molecules A in chamberÞ: [S1c]
Note that all propensities must have the same units, namely,
1
s× chamber area; i.e., the physical meaning of propensity is the reaction
ﬂux in an individual chamber on the surface. Unit consistency in
Eq. S1 requires the rate constants to have the different units
kA→B :
1
s
[S2a]
kAþB→C :
chamber area
molecules × s
[S2b]
kdiff A :
1
s
: [S2c]
One can see immediately that units of [S2b] are very different
from the ones used in bulk measurements for k2, namely
M− 1s− 1 ð Lmole× sÞ. Below we show how to transform experimental
value k2 in units M
−1·s−1 to the computational parameter kAþB→C
in units chamber areamolecules× s ,
k2
L
mole× s
¼ k2 10
− 3m3
6·1023 molecules× s
¼ k2·10
− 3
6·1023
1018μm× μm2
molecules× s
¼ k2·10
− 3·1018
6·1023
μm ×
104chambers
molecules× s
¼ k2·10
− 3·1018·104
6·1023
μm ×
chamber
molecules× s
;
[S3]
where we have used the fact that our contact area of 1 μm2
consists of 104 chambers.
The last step is to convert the 3D value of k2 into the two-
dimensional kAþB→C. To do that, we have to know a character-
istic length, corresponding to the conﬁnement of the proteins to
two-dimensional membrane. Usually, we assume that membrane
proteins can move in a direction perpendicular to the membrane
within the distance of ∼d = 10 Å = 10−3 μm. Thus,
k2·10− 3·1018·104
6·1023
μm ×
chambers
molecules × s
×
1
10− 3μm
¼ kAþB→C chambersmolecules× s [S4]
kAþB→C ¼ k2·10
− 3·1018·104
6·1023·10− 3
; [S5]
where k2 is in units M
−1·s−1 and kAþB→C is in units chamber areamolecules× s .
Note that for each particular choice of the individual chamber
size (which is determined by the range of interactions), one
should recalculate the value of kAþB→C accordingly, whereas
experimental value, naturally, does not change.
Rate of the diffusion process is estimated from the diffusion
rate constant D, which is usually measured in units μm2·s−1.
Here, we can simply multiply by the number of chambers in 1
μm2, which is 104 in this particular case:
kdiff ¼ D× 1041s: [S6]
Dose–Response Curves for Peptides of Different Strength. Another
possible test of the model would be to study the dose–response
curve that follows from simulation of the model. We choose
three different peptides: strong agonist (koff = 0.002), typical
agonist (koff = 0.02), and weak agonist (koff = 0.1) to see how the
dose–response curves change with different peptide quality.
We see (Fig. S8) that although strong peptides are capable of
signaling even without coreceptor, ability of weak agonist to
signal is critically dependent on the presence of coreceptor. As
mentioned in the main text, one might parallel this behavior to
experimentally determined classes of coreceptor-dependent and
coreceptor-independent peptides.
Cooperative Binding Is Required for MHC Stabilization on the T-Cell
Surface. Fig. S3 shows the enhancement of half-life ofMHCbound
to the T-cell surface in the situation when Lck cannot bind the
TCR’s intracellular domain. In this situation MHC interacts sep-
arately with TCR and coreceptor molecules present on the T-cell
surface and presence of coreceptor does not improve the half-life
of the MHC.
Parameter Sensitivity Studies. Parameter sensitivity studies were car-
ried out for parameters that have no experimental data available
(Table 1):
Fig. S3 illustrates that variations of kon,Lck–TCR (rate of Lck
engagement with TCR) within the range of 0.5–5 s−1 do not
change the qualitative picture resulting from simulations re-
ported in the main text.
Fig. S4 illustrates that variations of koff,Lck–TCR (rate of Lck
disengagement with TCR) within the range of 0.5–5 s−1 do not
change the qualitative picture resulting from simulations re-
ported in the main text.
Fig. S5 illustrates that variations of kp (rate of phosphorylation
of TCR by Lck) within the range of 0.02–0.2 s−1 do not change
the qualitative picture resulting from simulations reported in
the main text.
Fig. S6 illustrates that variations of kdp (rate of dephosphoryla-
tion of TCR) within the range of 0.05–0.5 s−1 do not change the
qualitative picture resulting from simulations reported in the
main text.
Fig. S1 illustrates that CD8-mediated stabilization of MHC
on the T-cell surface occurs also for ligands with fast dissocia-
tion kinetics (e.g., such asmeasured in ref. 1). The ﬁgure is analo-
gous to Fig. 2A shows results of simulations for pMHC with
koff(pMHC-TCR) = 0.2 s
−1 [Fig. 2A and shows simulation re-
sults for pMHC with koff(pMHC-TCR) = 0.02 s
−1].
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Fig. S9 illustrates that in the situation when strength of
coreceptor–MHC interaction is increased to very large values,
peptide speciﬁcity becomes unimportant and noncognate pep-
tides can activate the T cell.
1. Huppa JB, et al. (2010) TCR-peptide-MHC interactions in situ show accelerated kinetics
and increased afﬁnity. Nature 463:963–967.
Fig. S1. Effective half-life of MHC on the T-cell surface for pMHC characterized by koff(TCR–pMHC) = 0.2 s
−1 (i.e., 10 times faster than in the main text) as
a function of koff
MHC–coreceptor (which is proportional to afﬁnity of the MHC–coreceptor interaction) as obtained from the ﬁrst set of simulations (scheme 1 in
Fig. 1). At koff ∼ 20 s−1 the half-life is enhanced by ∼1.2 times in the presence of coreceptor, whereas at koff ∼ 80 s−1 half-lives with and without coreceptor are
statistically indistinguishable.
Fig. S2. Effective half-life of MHC on the T-cell surface as a function of koff
MHC-coreceptor (which is proportional to afﬁnity of the MHC–coreceptor interaction)
as obtained in the ﬁrst set of simulations (scheme 1 in Fig. 1) with association between Lck and TCR set to zero [kon(Lck–TCR) = 0]. One sees that in the absence
of cooperative binding (Fig. 2A) MHC is not stabilized on the surface.
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Fig. S3. Parameter sensitivity studies for kon(Lck–TCR). Amount of fully phosphorylated TCR is plotted a function of peptide quality (as determined by koff
TCR–pMHC).
TCR phosphorylation with and without coreceptor is shown for three cases: kon(Lck–TCR) = 0.5, 1, and 5 s
−1 (the rest of the parameters are the same as in
Table 1). Coreceptor-mediated enhancement does not change qualitatively when varying koff
TCR–pMHC.
Fig. S4. Parameter sensitivity studies for koff(Lck–TCR). Amount of fully phosphorylated TCR is plotted as a function of peptide quality (as determined by
koff
TCR–pMHC). TCR phosphorylation with and without coreceptor is shown for three cases: koff(Lck–TCR) = 0.5, 1, and 5 s
−1 (the rest of the parameters are the
same as in Table 1). Coreceptor-mediated enhancement does not change qualitatively when varying koff
TCR–pMHC .
Fig. S5. Parameter sensitivity studies for kp. Amount of fully phosphorylated TCR is plotted a function of peptide quality (as determined by koff
TCR–pMHC). TCR
phosphorylation with and without coreceptor is shown for three cases: kp = 0.02, 0.05, and 0.2 s
−1 (the rest of the parameters are the same as in Table 1).
Coreceptor-mediated enhancement does not change qualitatively when varying kp.
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Fig. S6. Parameter sensitivity studies for kdp. Amount of fully phosphorylated TCR is plotted as a function of peptide quality (as determined by koff
TCR–pMHC).
TCR phosphorylation with and without coreceptor is shown for three cases: kdp = 0.05, 0.2, and 0.5 s
−1 (the rest of the parameters are the same as in Table 1).
Coreceptor-mediated enhancement does not change qualitatively when varying kdp.
Fig. S8. Amount of fully phosphorylated TCR as a function of amount of peptides present in the contact area (dose–response curves) for strong agonist (A),
typical agonist (B), and weak agonist (C).
Fig. S7. Amount of fully phosphorylated TCR as a function of peptide quality (as determined by koff
TCR–pMHC). Coreceptor-mediated enhancement does not
change qualitatively when varying stability of coreceptor–MHC interactions between 20 s−1 (black curve) and 80 s−1 (blue curve).
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Fig. S9. Amount of fully phosphorylated TCR is plotted as a function of peptide quality (as determined by koff
TCR–pMHC) for different interaction afﬁnities
between coreceptor and MHC (black, koff
coreceptor–pMHC = 20 s−1; green, koff
coreceptor–pMHC = 2 s−1; blue, koff
coreceptor–pMHC = 0.2 s−1). The blue curve corresponds to
the situation when afﬁnity between coreceptor–MHC is similar to the afﬁnity of cognate MHC-TCR interactions.
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